L-ornithine L-aspartate in Overt Hepatic Encephalopathy
Condition(s):Cirrhosis of Liver; Hepatic EncephalopathyLast Updated:February 8, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Cirrhosis of Liver; Hepatic EncephalopathyLast Updated:February 8, 2017Completed
Condition(s):Infectious GastroenteritisLast Updated:February 4, 2015Completed
Condition(s):Leaky Gut SyndromeLast Updated:March 17, 2010Unknown status
Condition(s):Short Bowel SyndromeLast Updated:February 8, 2016Completed
Condition(s):Inflammatory Bowel DiseasesLast Updated:July 27, 2022Recruiting
Condition(s):Alcohol ConsumptionLast Updated:April 25, 2023Completed
Condition(s):Acute-On-Chronic Liver FailureLast Updated:December 3, 2018Withdrawn
Condition(s):ConstipationLast Updated:May 31, 2022Recruiting
Condition(s):Motility DisordersLast Updated:January 29, 2018Completed
Condition(s):Cirrhosis; Hepatic Encephalopathy; Minimal Hepatic Encephalopathy; Covert Hepatic EncephalopathyLast Updated:May 31, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.